VENTRUS BIOSCIENCES, INC. $20.0 Million of Common Stock (par value $0.001 per share) Controlled Equity Offeringsm Sales AgreementVentrus Biosciences Inc • January 31st, 2012 • Pharmaceutical preparations • New York
Company FiledJanuary 31st, 2012 Industry JurisdictionVentrus Biosciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: